Delivery Order SPE2DB22D2218-SPE2DB24FR2LU
- Not listed
- This federal contract award is for the delivery of Ivermectin 1% cream, 45 grams, valued at $2,820.78. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFLMZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ivermectin 1% cream 45g. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $1,089.69. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,020.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of 4568239606 - IVERMECTIN 1% CREAM 45GM, with a completion date of May 15, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $1,120.06 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ivermectin 1% cream, 45 gm, with a period of performance through June 11, 2025. The contract is not set-aside and was awarded on a competitive basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of IVERMECTIN 1% CREAM 45GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,542.93 and a ceiling value of $1,542.93. The ultimate completion date is December 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a for-profit...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,057.15 firm-fixed-price contract is for the supply of Ivermectin 1% Cream, 45 gm. The award has an ultimate completion date of June 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a comprehensive range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ivermectin 1% cream, a pharmaceutical product, with a ceiling value of $4,293.93 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, with ID SPE2DX15D3402|SPE2DX24F1KUJ, is for the delivery of Ivermectin 1% cream, 45-gram tubes, to the Defense Logistics Agency (DLA) Troop Support Medical. It is a firm-fixed-price delivery order contract with a ceiling value of $6,624.94 and an ultimate completion date of June 18, 2024. The award was made to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of...
- This federal contract award, with an ID of SPE2DX15D3018|SPE2DX24F9ZD9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,875.34, is for the delivery of Ivermectin 1% Cream 45GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 9, 2024. This award is not associated with a set-aside...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,552.84 firm fixed-price contract is for the delivery of Ivermectin 1% cream, a medication used to treat certain skin conditions. The contract is not designated as a set-aside and is therefore open to full and open competition. It has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor and...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB24FR2LUDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Ivermectin 1% cream. The $3,336.96 firm fixed price contract was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Additionally, Amerisourcebergen has a smaller IDC worth up to $750,000 with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/30/24 |